Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 31:9:46-51.
doi: 10.2174/1874306401509010046. eCollection 2015.

Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index

J Minov  1 , J Karadzinska-Bislimovska  1 , K Vasilevska  2 , S Stoleski  1 , D Mijakoski  1
Affiliations

Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index

J Minov et al. Open Respir Med J. .

Abstract

Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is a multidimensional disease, and no single isolated parameter is proved to have sufficient power for any overall determination of its severity and prognosis.

Objective: To compare the results of the assessment of the NCFB severity with respect to its prognosis in the same patients by two different validated scores, i.e. the FACED score and the Bronchiectasis Severity Index (BSI).

Methods: An observational study including 37 patients with NCFB (16 males and 21 female aged 46 to 76 years) was performed. All patients underwent evaluation of the variables incorporated in the FACED score (FEV1 % predicted, age, chronic colonization by Pseudomaonas aeruginosa, radiological extent of the disease, and dyspnea) and in the BSI (age, body mass index, FEV1 % predicted, hospitalization and exacerbations in previous year, dyspnea, chronic colonization by Pseudomaonas aeruginosa and other microrganisms, and radiological extent of the disease).

Results: According to the value of the derived overall FACED score we found 17 patients (45.9%) with mild bronchiectasis, 14 patients (37.8%) with moderate bronchiectasis and 6 patients (16.2%) with severe bronchiectasis. The mean derived FACED score was 3.4 ± 1.3. In addition, according to the value of the derived overall BSI score, the frequency of patients with low, intermediate and high BSI score was 16 patients (43,2%), 14 patients (37.8%) and 7 patients (18.9%), respectively. The mean derived BSI score was 6.4 ± 2.5.

Conclusion: We found similar results by the assessment of the NCFB severity in regard to its prognosis by both the FACED score and the BSI. Further studies determining how these scores may impact clinical practice are needed.

Keywords: Assessment; bronchiectasis; prognosis; score; severity.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Distribution of the patients by the FACED score.
Fig. (2)
Fig. (2)
Distribution of the patients by the BSI score.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Int Med. 2006;36(11):729–37. - PubMed
    1. Neves PC, Guerra M, Ponce P, Miranda J, Vouga L. Non-cystic fibrosis bronchiectasis. Interact Cardiovasc Thorac Surg. 2011;13:619–25. - PubMed
    1. Hogg C. Primary ciliary dyskinesia when to suspect the diagnosis and how to confirm it. Pediatr Respir Rev. 2009;10:44–50. - PubMed
    1. Lujan M, Gallardo X, Amengual MJ, Bosque M, Mirapeix RM, Domingo CH. Prevalence of bronchiectasis in asthma according to oral steroid requirements influence of immunoglobulin levels. Biomed Research International. 2013 - PMC - PubMed
    1. Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20(2):135–40. - PMC - PubMed

LinkOut - more resources